ReviewNAM perspectives2020
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.
Review in NAM perspectives, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
144 citing papers in PubMed, 2 syntheses or guidelines pooled it, 232 citations in OpenAlex.
- Patient-reported outcomes for monitoring substance use treatment: A systematic review of single-item measures.Addiction (Abingdon, England) · 2026Pooled it
- Interventions for hospitalized medical and surgical patients with opioid use disorder: A systematic review.Substance abuse · 2022Pooled it
- Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.The New England journal of medicine · 2024Trial
- Machine Learning-Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention.Journal of addiction medicineTrial
- Association Between Integrated Treatment Services and Access to Detoxification and MOUD Across US Treatment Facilities.The journal of behavioral health services & research · 2026Article
- Preparing Emergency Medical Services for Prehospital Buprenorphine: Examining a Train-the-Trainer Approach to Strengthening the Overdose Chain of Survival.Journal of the American College of Emergency Physicians open · 2026Article
- Global perspectives on telemedicine-enabled medications for opioid use disorder: Practices, priorities, and barriers.Journal of telemedicine and telecare · 2026Article
- Opioid use disorder medication treatment in residential settings increased 2017-2021, but sustaining it following stays remains an issue.Health affairs scholar · 2026Article
- Assessing usability and acceptability of a VR digital therapeutic for treatment of substance use disorders.Journal of social work practice in the addictions · 2026Article
- Implementation and evaluation of a secret shopper methodology to examine access to prenatal care for patients with opioid use disorder.BMC pregnancy and childbirth · 2026Article
- Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach.Addiction (Abingdon, England) · 2026Article
- Self-reported cannabis use to manage opioid withdrawal symptoms and reductions in opioid use among people who use unregulated opioids: a cross-sectional analysis.Journal of cannabis research · 2026Article
- "The alternative is they're not getting care at all": a qualitative interview study of opioid use disorder treatment providers' perspectives on quality and appropriateness of telehealth for buprenorphine access.Harm reduction journal · 2026Article
- Factors Associated with Primary Care, Behavioral Health, and Emergency Department Utilization Among Men with Opioid Use Disorder and Criminal-Legal Involvement: A Cross-Sectional Study.Research square · 2026Article
- IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccine.Biomaterials · 2026Article
- Social Determinants of Health and 1-Year Buprenorphine Initiation Among Justice-Involved Veterans.JAMA network open · 2026Article
- Sociodemographic Characteristics and Drug Use Practices Associated with Fentanyl Use Frequency Among People Who Use Drugs in Rhode Island.Substance use & misuse · 2026Article
- Implementation and outcomes of a multifaceted care model for people experiencing homelessness and people who inject drugs hospitalized with complicated infections.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- Leveraging pharmacy partnerships and Grant funding to improve access to medications for opioid use disorder.Exploratory research in clinical and social pharmacy · 2025Article
- Identifying Barriers and Facilitators to Pain Management With Buprenorphine for Patients With Kidney Failure: A Thematic Analysis of Interviews With Key Partners.Kidney medicine · 2025Article
84 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost four in five Americans with OUD do not receive any form of treatment. The gap in access to evidence-based care, including treatment with medications for OUD, stems in part from barriers to change within the health care system. This paper includes nine key barriers that prevent access to evidence-based care, including stigma; inadequate clinical training; a dearth of addiction specialists; lack of integration of MOUD provision in practice; regulatory, statutory, and data sharing restrictions; and financial barriers. Action from a number of actors is urgently needed to address this crisis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.